Liminatus Pharma, Inc. (LIMN)
3.76
+0.07
(+1.90%)
USD |
NASDAQ |
Oct 09, 16:00
3.78
+0.02
(+0.53%)
After-Hours: 20:00
Liminatus Pharma Net Income (Quarterly) : -1.407M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.407M |
| March 31, 2026 | -1.124M |
| December 31, 2025 | -8.169M |
| September 30, 2025 | -1.823M |
| June 30, 2025 | 0.1133M |
| March 31, 2025 | -0.3275M |
| December 31, 2024 | -0.2298M |
| September 30, 2024 | -0.6014M |
| June 30, 2024 | -0.9612M |
| March 31, 2024 | -0.0002M |
| December 31, 2023 | -0.4866M |
| September 30, 2023 | -0.3239M |
| Date | Value |
|---|---|
| June 30, 2023 | 0.233M |
| March 31, 2023 | -0.6487M |
| December 31, 2022 | -0.0106M |
| September 30, 2022 | 2.732M |
| June 30, 2022 | 3.713M |
| March 31, 2022 | 3.816M |
| December 31, 2021 | -0.2678M |
| September 30, 2021 | 6.762M |
| June 30, 2021 | -0.1611M |
| March 31, 2021 | -1.963M |
| December 31, 2020 | -0.0013M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.407M |
| EPS Diluted (Quarterly) | -72.70 |
| Enterprise Value | -1.490M |
| Earnings Yield | -28.57K% |
| Normalized Earnings Yield | -14147.98 |